U.K.-based Drs. Antoni Nargol and David Langton alleged in a 2012 lawsuit that Johnson & Johnson and its subsidiary DePuy Orthopaedics defrauded the government by advertising defective hip replacement devices. The surgeons alleged a hip replacement implant in the “Pinnacle” portfolio was illegally promoted and sold by the company over a five-year period. In 2021, their case was tossed over claims the plaintiffs misused confidential records.
However, those claims have been disputed in an appeal, according to court documents filed May 17 in the U.S. Court of Appeals for the First Circuit. The 2021 dismissal zeroed in on information that was allegedly under a protective order at the time it was filed. According to the surgeons’ May 17 appeal, information they incorporated into their complaint was public and not subject to any relevant protective order.
Johnson & Johnson and DePuy Synthes attempted through legal means to make the surgeons pay $2.4 million after their whistleblower case was tossed. However, a federal judge denied the motion in January.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.